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Correction to: British Journal of Cancer (2008) 99, 822–829,
doi:10.1038/sj.bjc.6604564
Owing to an error during typesetting, there were some mistakes
introduced into the layouts of Tables 2 and 3 in the above
paper when first published in the British Journal of Cancer in
September 2008. The presentation of the tables as such may have
led to misinterpretation of data; indeed, some data were presented
incorrectly in Table 3.
The tables are now reproduced, as the author intended, on the
following pages.
The publishers would like to apologise for these errors.
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www.bjcancer.comTable 2 Standardised mortality ratios (SMR) for all asbestos removal workers in the survey and for those included in the analysis (1971–2005)
All removal workers Analysed workers
Cause of death Deaths
SMR
(95% CI) Deaths
SMR
(95% CI)
All causes 3165 122.9** 985 111.3**
(118.7–127.3) (104.4–118.4)
All MN 1274 173.1** 384 169.2**
(163.7–182.9) (152.7–187.0)
MN of lip, oral cavity and pharynx 19 94.0 6 83.7
(56.6–146.9) (30.7–182.2)
MN of oesophagus 42 88.2 16 104.2
(63.5–119.2) (59.6–169.2)
MN of stomach 49 133.7 18 176.4*
(98.9–176.8) (104.5–278.8)
MN of colon 62 127.9 17 119.2
(98.1–163.9) (69.4–190.9)
MN of rectum 43 169.0** 15 207.1*
(122.3–227.6) (115.9–341.5)
MN of liver (primary) 20 126.6 9 167.8
(77.3–195.5) (76.7–318.6)
MN of larynx 17 212.3** 8 322.9**
(123.6–339.8) (139.4–636.1)
MN trachea, bronchus and lung 393 200.5** 115 215.6**
(181.2–221.4) (178.0–258.7)
MN of peritoneum 38 4568.9** 12 4367.8**
(3233.2–6271.2) (2257.0–7629.8)
MN of pleura 35 1149.3** 10 1332.8**
(800.5–1598.4) (639.1–2451.1)
Mesothelioma
a 69 808.2** 23 808.2**
(628.8–1022.8) (512.3–1212.7)
MN of ovary 0 — 0 —
(0.0–533.0) (0.0–7092.9)
MN of kidney 29 160.1* 13 229.0*
(107.2–229.9) (121.9–391.6)
MN of bladder 18 94.2 3 61.6
(55.8–148.8) (12.7–180.2)
MN of lymphatic and haematopoietic tissue 80 103.9 24 86.2
(82.4–129.3) (55.2–128.2)
Circulatory disease 981 114.0** 258 102.0
(107.0–121.4) (89.9–115.2)
Ischaemic heart disease 665 113.3** 171 102.4
(104.9–122.3) (87.7–119.0)
Cerebrovascular disease 147 125.0* 41 118.3
(105.6–146.9) (84.9–160.5)
Respiratory disease 222 128.0** 44 88.8
(111.7–146.0) (64.5–119.2)
Asbestosis
b 22 5753.4** 3 3849.6**
(3605.6–8710.7) (794.3–11249.8)
CI¼confidence interval. *Significant at Pp0.05; **significant at Pp0.01.
aICD-10, after 2001.
bAsbestosis determined by underlying cause of death.
Erratum
1955Table 3 Relative risks (RRs) of mortality for stripping/removal workers, using Poisson regression analyses
All causes All MN MN trachea, bronchus and lung
Cases RR
a (95% CI) LR test (d.f.) Cases RR
a (95% CI) LR test (d.f.) Cases RR
a (95% CI) LR test (d.f.)
Main stripping method 4.03 (2) 2.35 (2) 2.71 (2)
Wet
c 397 1.0 141 1.0 48 1.0
Dry 409 1.1 (0.9–1.2) 169 1.2 (0.9–1.5) 39 0.8 (0.5–1.2)
Both 48 0.8 (0.6–1.1) 21 1.0 (0.6–1.6) 13 1.3 (0.7–2.7)
Main respirator type 2.82 (6) 10.20 (6) 6.28 (6)
Positive pressure mask
c 664 1.0 245 1.0 70 1.0
Airstream helmet 4 — 1 — 1 —
Full face unpowered mask 127 1.0 (0.8–1.2) 55 1.1 (0.8–1.5) 16 1.1 (0.6–1.8)
Half face mask 18 0.8 (0.5–1.3) 4 — 1 —
Minimal 14 0.7 (0.4–1.3) 5 — 2 —
N o n e 2— 2— 1 —
Mixed 51 1.1 (0.8–1.5) 25 1.4 (0.9–2.2) 11 1.7 (0.9–3.5)
Weekly hours spent stripping 14.97 (4)** 1.00 (4) 0.87 (4)
o10
c 483 1.0 222 1.0 66 1.0
10  74 1.0 (0.8–1.2) 32 1.0 (0.7–1.5) 8 0.9 (0.4–1.8)
20  125 1.1 (0.9–1.4) 48 1.1 (0.8–1.5) 12 1.0 (0.5–1.8)
30  124 1.3 (1.0–1.5)* 33 0.9 (0.6–1.3) 9 0.9 (0.4–1.7)
40+ 163 1.4 (1.2–1.7)** 44 1.0 (0.7–1.4) 15 1.2 (0.7–2.1)
Smoking status 112.42 (2)** 41.07 (2)** 67.66 (2)**
Never smokers
c 118 1.0 38 1.0 1 1.0
Current smokers 622 2.5 (2.0–3.0)** 216 2.8 (1.9–3.9)** 86 43.0 (6.0–305.8)**
Former smokers 225 1.5 (1.2–1.9)** 125 2.2 (1.5–3.1)** 26 16.0 (2.2–118.4)**
Age at first exposure (years) 14.80 (4)** 13.41 (4)** 3.22 (4)
o20
c 184 1.0 91 1.0 21 1.0
20  278 1.1 (0.9–1.3) 81 0.9 (0.7–1.2) 18 1.0 (0.5–1.8)
30  193 0.9 (0.8–1.1) 70 0.8 (0.6–1.1) 23 1.2 (0.7–2.1)
40  211 1.1 (0.9–1.3) 84 0.7 (0.5–1.0)* 33 1.2 (0.7–2.0)
50+ 119 0.7 (0.6–0.9)** 58 0.6 (0.4–0.8)** 20 0.7 (0.4–1.3)
Length of time in the survey 0.01 (1) 14.81 (1)** 5.13 (1)*
Short term
c 419 1.0 116 1.0 33 1.0
Long term 599 1.0 (0.9–1.1) 268 1.5 (1.2–1.9)** 82 1.6 (1.1–2.4)*
Length of exposure (years) 16.29 (4)** 18.61 (4)** 6.88 (4)
o10
c 553 1.0 166 1.0 49 1.0
10  161 1.0 (0.8–1.2) 60 1.1 (0.8–1.5) 26 1.6 (1.0–2.5)
20  88 0.8 (0.7–1.0) 45 1.1 (0.8–1.5) 11 0.8 (0.4–1.6)
30  94 1.0 (0.8–1.2) 61 1.4 (1.1–1.9)* 14 1.0 (0.5–1.8)
40+ 89 1.5 (1.2–2.0)** 52 2.1 (1.5–2.9)** 15 1.7 (0.9–3.2)
Time of first exposure 0.00 (1) 4.02 (1)* 1.43 (1)
Pre-ALR
c 430 1.0 217 1.0 66 1.0
Post-ALR 555 1.0 (0.9–1.1) 167 0.8 (0.7–1.0)* 49 0.8 (0.5–1.2)
Mesothelioma
b Circulatory disease Ischaemic heart disease
Cases RR
a (95% CI) LR test (d.f.) Cases RR
a (95% CI) LR test (d.f.) Cases RR
a (95% CI) LR test (d.f.)
Main stripping method 3.25 (2) 6.81 (2)* 8.61 (2)*
Wet
c 12 1.0 109 1.0 77 1.0
Dry 10 0.9 (0.4–2.1) 107 1.0 (0.7–1.3) 66 0.9 (0.6–1.2)
Both 0 — 7 0.4 (0.2–0.9)* 3 —
Main respirator type 10.14 (6) 1.54 (6) 2.24 (6)
Positive pressure mask
c 20 1.0 172 1.0 110 1.0
Airstream helmet 0 — 1 — 1 —
Full face unpowered mask 1 — 34 1.0 (0.7–1.4) 24 1.1 (0.7–1.7)
Half face mask 0 — 7 1.1 (0.5–2.5) 5 —
Minimal 0 — 4 — 2 —
N o n e 1— 0— 0 —
Mixed 1 — 12 1.0 (0.5–1.7) 9 1.2 (0.6–2.3)
Weekly hours spent stripping 2.29 (1) 12.34 (4)* 11.42 (4)*
o10
c 17 1.0 133 1.0 86 1.0
10  6 0.5 (0.2–1.3) 16 0.8 (0.5–1.4) 12 1.0 (0.5–1.8)
20  — 28 1.1 (0.7–1.6) 16 0.9 (0.6–1.6)
30  — 32 1.4 (0.9–2.1) 24 1.6 (1.0–2.6)*
40+ — 47 1.7 (1.2–2.4)** 32 1.9 (1.2–2.8)**
Smoking status 2.27 (2) 33.41 (2)** 35.14 (2)**
Never smokers
c 5 1.0 38 1.0 19 1.0
Current smokers 7 0.7 (0.2–2.3) 161 2.1 (1.4–2.9)** 114 2.9 (1.8–4.7)**
Former smokers 11 1.5 (0.5–4.4) 53 0.9 (0.6–1.4) 34 1.2 (0.7–2.1)
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1956Age at first exposure (years) 22.12 (1)** 12.38 (4)* 12.71 (4)*
o20
c 14 1.0 44 1.0 33 1.0
20  9 0.1 (0.1–0.3)** 41 0.8 (0.5–1.2) 19 0.5 (0.3–0.9)*
30  — 51 1.0 (0.7–1.6) 34 0.9 (0.6–1.5)
40  — 78 1.5 (1.0–2.2)* 54 1.3 (0.9–2.1)
50+ — 44 0.9 (0.6–1.4) 31 0.9 (0.5–1.5)
Length of time in the survey 8.23 (1)** 0.00 (1) 0.60 (1)
Short term
c 3 1.0 102 1.0 72 1.0
Long term 20 4.5 (1.3–16.0)* 156 1.0 (0.8–1.3) 99 0.9 (0.6–1.2)
Length of exposure (years) 18.59 (1)** 7.19 (4) 10.39 (4)*
o10
c — 141 1.0 92 1.0
10  — 48 1.0 (0.7–1.4) 36 1.2 (0.8–1.7)
20  9
d 1.0 27 0.8 (0.5–1.2) 14 0.6 (0.3–1.0)
30  14 7.3 (2.5–21.6)** 20 0.6 (0.4–0.9)* 13 0.6 (0.3–1.0)*
40+ — 22 0.9 (0.6–1.5) 16 1.1 (0.6–1.9)
Time of first exposure 13.15 (1)** 0.46 (1) 0.84 (1)
Pre-ALR
c 19 1.0 123 1.0 81 1.0
Post-ALR 4 — 135 1.1 (0.8–1.4) 90 1.2 (0.8–1.6)
Cerebrovascular disease Respiratory disease
Cases RR
a (95% CI) LR test (d.f.) Cases RR
a (95% CI) LR test (d.f.)
Main stripping method 0.62 (2) 2.46 (2)
Wet
c 18 1.0 23 1.0
Dry 14 0.8 (0.4–1.5) 13 0.6 (0.3–1.2)
Both 2 — 4 —
Main respirator type 7.12 (6) 4.02 (6)
Positive pressure mask
c 31 1.0 33 1.0
Airstream helmet 0 — 0 —
Full face unpowered mask 4 — 4 —
Half face mask 0 — 0 —
Minimal 1 — 1 —
N o n e 0— 0—
Mixed 0 — 3 —
Weekly hours spent stripping 0.68 (2) 3.46 (3)
o10
c 21 1.0 21 1.0
10  10 1.4 (0.6–2.9) 8 1.1 (0.5–2.5)
30  10 1.2 (0.6–2.7) 7 2.0 (0.8–4.6)
40+ — 8 1.9 (0.9–4.1)
Smoking status 5.96 (2) 14.18 (2)**
Never smokers
c 12 1.0 2 1.0
Current smokers 22 0.9 (0.4–1.8) 30 7.4 (1.8–30.6)**
Former smokers 6 0.3 (0.1–0.9)* 11 3.8 (0.8–17.2)
Age at first exposure (years) 3.04 (4) 4.35 (3)
o20
c 6 1.0 6 1.0
20  8 1.1 (0.4–3.2) 12 1.7 (0.7–4.8)
30  8 1.5 (0.5–4.7) 12 2.1 (0.8–5.3)
40  12 2.2 (0.8–6.6) 14 1.0 (0.4–2.6)
50+ 7 1.3 (0.4–4.4) —
Length of time in the survey 0.45 (1) 0.46 (1)
Short term
c 15 1.0 20 1.0
Long term 26 1.2 (0.7–2.3) 24 0.8 (0.5–1.5)
Length of exposure (years) 0.94 (2) 7.14 (3)
o10
c 24 1.0 25 1.0
10  6 0.8 (0.3–1.9) 6 0.4 (0.2–1.1)
20  11 0.7 (0.3–1.5) —
30  — 6 1.1 (0.4–2.7)
40+ — 7 1.9 (0.8–4.4)
Time of first exposure 1.16 (1) 0.01 (1)
Pre-ALR
c 18 1.0 22 1.0
Post-ALR 23 1.4 (0.7–2.8) 22 1.0 (0.5–1.8)
CI¼confidence interval; d.f.¼degrees of freedom; LR test¼likelihood ratio test of goodness-of-fit. *significant at Pp0.05; **significant at Pp0.01.
aRelative risk adjusted with
Poisson regression for age, calendar period and sex.
bICD-10, after 2001.
cReference category.
dCategories: o30, 30+.
Table 3 (Continued)
Mesothelioma
b Circulatory disease Ischaemic heart disease
Cases RR
a (95% CI) LR test (d.f.) Cases RR
a (95% CI) LR test (d.f.) Cases RR
a (95% CI) LR test (d.f.)
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